DAVENPORT FRED B JR
SEC CIK 1181154 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MEDP | Medpace Holdings, Inc. | Dir | 11.1K | $72.9K | $8.41M | 7 | 2022-02-17 | 2026-08-19 |
Most active insiders at MEDP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Troendle August J. | Pres, CEO, Dir, 10% | — | $299.14M |
| 2 | GEIGER JESSE J | Pres | — | $41.11M |
| 3 | BURWIG SUSAN E | EVP, Ops | — | $28.78M |
| 4 | EWALD STEPHEN P | GC, Corp. Secy | — | $16.48M |
| 5 | DAVENPORT FRED B JR | Dir | — | $7.89M |
| 6 | Kraft Robert O. | Dir | — | $6.21M |
| 7 | Brady Kevin M. | CFO, Treas | — | $3.90M |
| 8 | Carley Brian T | Dir | — | $3.04M |
| 9 | McCarthy Cornelius P. III | Dir | — | $1.16M |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-21 16:11 | 2026-08-19 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | M - OptEx | $116.08 | +7,583 | 11.1K | +217% | +$880.3K |
| D | 2026-08-21 16:11 | 2026-08-19 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | S - Sale+OE | $606.15 | -7,283 | 3,798 | -66% | -$4.41M |
| D | 2025-11-03 | 2025-10-30 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | S - Sale+OE | $581.88 | -5,972 | 3,498 | -63% | -$3.47M |
| D | 2025-11-03 | 2025-10-30 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | M - OptEx | $54.99 | +6,472 | 9,470 | +216% | +$355.9K |
| D | 2025-04-28 | 2025-04-24 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | M - OptEx | $57.17 | +4,710 | 4,710 | New | +$269.3K |
| D | 2025-04-28 | 2025-04-24 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | S - Sale+OE | $301.82 | -1,712 | 2,998 | -36% | -$516.7K |
| I | 2022-02-22 | 2022-02-17 | MEDP | Medpace Holdings, Inc. | DAVENPORT FRED B JR | Dir | P - Purchase | $145.80 | +500 | 2,000 | +33% | +$72.9K |
Purchase Sale Sale after option exercise All abbreviations